AAAAAA

   
Results: 1-12 |
Results: 12

Authors: Modugno, F Weissfeld, JL Trump, DL Zmuda, JM Shea, P Cauley, JA Ferrell, RE
Citation: F. Modugno et al., Allelic variants of aromatase and the androgen and estrogen receptors: Toward a multigenic model of prostate cancer risk, CLIN CANC R, 7(10), 2001, pp. 3092-3096

Authors: Fitzpatrick, AL Daling, JR Furberg, CD Kronmal, RA Weissfeld, JL
Citation: Al. Fitzpatrick et al., Hypertension, heart rate, use of antihypertensives, and incident prostate cancer, ANN EPIDEMI, 11(8), 2001, pp. 534-542

Authors: Subar, AF Ziegler, RG Thompson, FE Johnson, CC Weissfeld, JL Reding, D Kavounis, KH Hayes, RB
Citation: Af. Subar et al., Is shorter always better? Relative importance of questionnaire length and cognitive ease on response rates and data quality for two dietary questionnaires, AM J EPIDEM, 153(4), 2001, pp. 404-409

Authors: Weissfeld, JL
Citation: Jl. Weissfeld, Cyclin D1 and esophageal adenocarcinoma risk: How good does a marker have to be?, J NAT CANC, 92(16), 2000, pp. 1282-1283

Authors: Prorok, PC Andriole, GL Bresalier, RS Buys, SS Chia, D Crawford, ED Fogel, R Gelmann, EP Gilbert, F Hasson, MA Hayes, RB Johnson, CC Mandel, JS Oberman, A O'Brien, B Oken, MM Rafla, S Reding, D Rutt, W Weissfeld, JL Yokochi, L Gohagan, JK
Citation: Pc. Prorok et al., Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, CONTR CL TR, 21(6), 2000, pp. 273S-309S

Authors: Hayes, RB Reding, D Kopp, W Subar, AF Bhat, N Rothman, N Caporaso, N Ziegler, RG Johnson, CC Weissfeld, JL Hoover, RN Hartge, P Palace, C Gohagan, JK
Citation: Rb. Hayes et al., Etiologic and early marker studies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, CONTR CL TR, 21(6), 2000, pp. 349S-355S

Authors: Weissfeld, JL Fagerstrom, RM O'Brien, B
Citation: Jl. Weissfeld et al., Quality control of cancer screening examination procedures in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, CONTR CL TR, 21(6), 2000, pp. 390S-399S

Authors: Miller, AB Yurgalevitch, S Weissfeld, JL
Citation: Ab. Miller et al., Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, CONTR CL TR, 21(6), 2000, pp. 400S-406S

Authors: Modugno, F Weissfeld, JL Hill, LM
Citation: F. Modugno et al., Reproducibility in the assessment of postmenopausal ovaries with transvaginal ultrasound, GYNECOL ONC, 77(2), 2000, pp. 289-292

Authors: Schoen, RE Weissfeld, JL Bowen, NJ Switzer, G Baum, A
Citation: Re. Schoen et al., Patient satisfaction with screening flexible sigmoidoscopy, ARCH IN MED, 160(12), 2000, pp. 1790-1796

Authors: Alexander, FE Andriole, GL Aus, G Auvinen, A Beensterboer, P Blijenberg, BG Bonardi, R Buys, S Candas, B Ciatto, S Crawford, ED Demers, R de Koning, HJ Denis, L Dijk, MA Figueiredo, F Gellman, EP Gohagan, J Hakama, M Hugosson, J Kirkels, WI Kranse, R van der Kwast, TH Lilja, H Maattanen, L Mandel, J Miller, AB Monteiro, H Nelen, V Oberman, A Paez, A Prorok, PC Reding, D Rietbergen, JWBW Rose, DB Sanchez, AB Schroder, FH da Silva, EC Simpson, N Smith, PH Stadaert, B Stenman, UH Teppo, L Turkes, A Weissfeld, JL Yokochi, L
Citation: Fe. Alexander et al., Rationale for randomised trials of prostate cancer screening, EUR J CANC, 35(2), 1999, pp. 262-271

Authors: Wu, Y Weissfeld, JL Weinberg, GB Kuller, LH
Citation: Y. Wu et al., Screening mammography and late-stage breast cancer: A population-based study, PREV MED, 28(6), 1999, pp. 572-578
Risultati: 1-12 |